December 31, 2022
The trends plastic surgeons and dermatologists are seeing in practice by Jennifer Holman, MD, FAAD, and Chris Surek, DO, FACS.
December 30, 2022
Dr. Stephen Matlock, a dermatologist, is practicing in Joplin, the town where he grew up and where his father, also a dermatologist, worked.
December 28, 2022
There are many reasons for itchy skin, but it may be especially common and pertinent
December 27, 2022
Rural communities represent some of our most underserved regions, presenting a long-simmering dermatology crisis that requires our immediate attention.
December 23, 2022
Paul Singh, CEO of U.S. Dermatology Partners is recognized in Becker’s Hospital Review’s Rising Stars: 104 Healthcare Leaders to Know
December 20, 2022
Board-Certified Dermatologist Jaqueline Watchmaker shares the differences between eczema and dry skin and how to treat them with a few simple steps.
December 14, 2022
Eczema is one of the most common chronic skin conditions, impacting more than 30 mill
December 8, 2022
13 Best Treatments for Keratosis Pilaris, According to Dermatologists You know how your skin can get all goosebumpy when you watch a Jordan Peele movie, or you go out in the first chill of autumn wearing a short-sleeved tee? Well, for some people, those bumps are a constant presence, and they have nothing to do
December 8, 2022
Sterling, Virginia – U.S. Dermatology Partners Welcomes Dermatologist Dr. Fiona Shaw to Their Sterling, Virginia Clinic Location
December 7, 2022
Dry, flaky, peeling skin doesn’t feel great, and it can look even worse. If you’r
December 6, 2022
Cedar Park, Texas – U.S. Dermatology Partners Welcomes Maria Jones, PA-C to Their Cedar Park, TX Office
December 1, 2022
Dr. Stephen Matlock at U.S. Dermatology Partners in Jolpin, MO is now offering Mohs surgery to treat many different kinds of skin cancer.
November 30, 2022
When it comes to turning back the clock on aging skin, no word gets used more frequen
November 30, 2022
Abstract Background: Limited data exists for bupivacaine injection after Mohs micrographic surgery (MMS). Objective: Evaluate how bupivacaine affects postoperative pain and narcotic use. Materials and methods: In this multicenter, single-blinded, prospective randomized controlled trial, patients received bupivacaine or saline (placebo) immediately after MMS with flap reconstructions identified by American Academy of Dermatology expert consensus as high-risk for pain
Get the latest updates on news, specials and skin care information.
